SANUWAVE reports record FY2022 revenue of $16.7M, restates prior quarterly financials

SANUWAVE Health, Inc.

2023-Q1 EPS reported -$0.02 revenue$3,775,000

FY2022 revenue $16.7M (+29% YoY); Q4 revenue $5.5M (+32% vs Q3 2022).
GAAP operating loss improved to $9.0M in FY2022 from $14.1M in 2021; Q4 op loss $1.5M.
Restated Q1, Q2, Q3 2022 financials due to material errors in accounting for shares, asset sales, vendor invoices, interest, inventory.
Q1 2023 guidance: revenue growth 14-20% vs Q1 2022; supply constraint alleviated.
New executives added (EVP Sales, VP Commercial Ops, VP Ops); stock now trades on OTCQB.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SANUWAVE Health, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $5.5 million. Guidance initiated.

Period: the fourth quarter ended December 31, 2022
Revenue: $5.5 million
Guidance: initiated
Result: reported results

Exact text from the filing

Revenues increased by 32% to $5.5 million for the fourth quarter ended December 31, 2022

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SANUWAVE Health, Inc. reported the year ended December 31, 2022 results: revenue $16.7 million. Guidance initiated.

Period: the year ended December 31, 2022
Revenue: $16.7 million
Guidance: initiated
Result: reported results

Exact text from the filing

Revenues increased by 29% to $16.7 million for the year ended December 31, 2022

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

SANUWAVE Health, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-015888

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.